Skip to content
  • Home
  • World News
  • Business
  • Aviation
195 news

195News

All the news that's fit to print

  • Home
  • World News
  • Business
  • Aviation
  • Toggle search form
  • UK Based Leading Mobility Specialist Now Running Dubai Clinic For Wheelchair Users
    UK Based Leading Mobility Specialist Now Running Dubai Clinic For Wheelchair Users Business
  • Increased Sun Exposure And Tanning Habits of Individuals
    Increased Sun Exposure And Tanning Habits of Individuals World News
  • “Transitioning Furniture Business Online” – Omnichannel Specialists YRC Explain Why
    “Transitioning Furniture Business Online” – Omnichannel Specialists YRC Explain Why Business
  • Users Share Their Transformative Experiences
    Users Share Their Transformative Experiences Business
  • Day 369: war diaries w/Former Advisor to Ukraine President, Intel Officer @arestovych & #Feygin
    Day 369: war diaries w/Former Advisor to Ukraine President, Intel Officer @arestovych & #Feygin World News
  • Bidtellect Speaks at Digiday Media Buying Summit on Managing Carbon Footprint in Advertising Following Latest Published Piece
    Bidtellect Speaks at Digiday Media Buying Summit on Managing Carbon Footprint in Advertising Following Latest Published Piece Business
  • Massachusetts Opens Probe Targeting Gov. DeSantis Over Sending Migrants To Martha’s Vineyard
    Massachusetts Opens Probe Targeting Gov. DeSantis Over Sending Migrants To Martha’s Vineyard World News
  • Allulose Market will Gain Momentum by 2032 to Surpass 8.2 Million
    Allulose Market will Gain Momentum by 2032 to Surpass $308.2 Million World News
Solaris Endovascular, Inc. Launches to Revolutionize Vascular Health Solutions Globally

Solaris Endovascular, Inc. Launches to Revolutionize Vascular Health Solutions Globally

Posted on November 15, 2024 By NewsEditor

Solaris Endovascular, Inc. Launches to Revolutionize Vascular Health Solutions Globally

Solaris Endovascular Inc

Solaris SX is very flexible

Solaris SX Flexibility

NEW ORLEANS, LA, UNITED STATES, November 13, 2024 /EINPresswire.com/ — Solaris Endovascular, Inc. Launching to Address Vascular Health Challenges Globally

Solaris Endovascular, Inc. proudly announces its formation to develop solutions for Dialysis Access and Peripheral Artery Disease (PAD). Solaris Endovascular develops evidence-based technologies, intended to treat and extend the patency of dialysis access fistulae, grafts, and peripheral arteries to allow patients to lead healthier lives with fewer interventions.

End-Stage Kidney Disease (ESKD) is a major health concern affecting approximately 10 million people worldwide with approximately 3 million people receiving kidney replacement therapy and relying on hemodialysis to survive. Over 50% of these patients experience vascular access failures within the first year and are subjected to hospital admissions and repeated costly endovascular or surgical interventions to restore their lifeline to dialysis—this drastically impacts quality of life, treatment effectiveness and survival.

In April 2024, the American Heart Association reported that the global prevalence of peripheral artery disease (PAD) may be as high as 230 million people. PAD can progress from painful walking to critical limb ischemia, and many patients require revascularization procedures to restore blood flow, improve symptoms, or prevent amputations.

Stent-grafts are emerging as the preferred minimally invasive treatment for these conditions and Solaris Endovascular is currently selling the latest generation of stent-grafts. The flagship Solaris(TM) SX Vascular Stent Graft employs the most advanced electrospinning PTFE impermeable membrane that prevents tissue ingrowth, maximizes patency, and reduces restenosis. This thin, multi-directional PTFE membrane encapsulates a nitinol stent that provides flexibility, high radial strength, and crush resistance for optimal blood flow. These features are already proven in global markets with more than 13,000 units sold to date. Interventional and endovascular physicians worldwide have chosen Solaris SX for its trackability and precise pinpoint deployment, ensuring accurate placement.

“Bringing this innovative technology to the United States is a major step forward in improving the lives of patients,” said Dr. Marco Costa, Chairman and Chief Medical & Scientific Officer at Solaris Endovascular Inc. “Solaris Endovascular’s advanced covered stent platforms will not only reduce the burden of repeated interventions but will also dramatically enhance the quality of life and life expectancy for those who suffer from these debilitating conditions.”

Looking ahead, Solaris Endovascular is already enrolling patients in clinical trials for the first of its kind Solaris(TM) DE Drug-Eluting Vascular Stent Graft – that will address the remaining unmet need in covered stents: edge stenosis. Solaris DE incorporates Sirolimus, a powerful and safe anti-proliferative agent that revolutionized the treatment of coronary artery disease with the virtual elimination of restenosis, from 30% to 3%.

“We expect Solaris DE to deliver similar transformative results to patients with ESKD and PAD,” said Dr. Costa.

CEO Randy Hubbell emphasized the company’s unique position in the market: “Solaris Endovascular represents a rare opportunity to start a new company that is revenue producing from the beginning, has a decade-plus manufacturing expertise in stents, stent grafts and endovascular drug delivery, and a proven product supported by clinical studies in multiple markets before entering the U.S. Our platform addresses a significant unmet need in both dialysis access and PAD, offering life-changing solutions for patients while setting a new standard in endovascular care.”

As Solaris Endovascular prepares for the U.S. registration process, it is committed to driving meaningful improvements in patient outcomes, reducing hospital readmissions, and lowering overall healthcare costs.

About Solaris Endovascular, Inc.

Solaris Endovascular, Inc. is a growth stage US-based medical device company developing advanced endovascular solutions for patients suffering from dialysis access challenges and Peripheral Artery Disease. With a proven stent platform and innovative drug-eluting technology, led by seasoned executives with extensive experience in cardiovascular MedTech, Solaris Endovascular is uniquely positioned and committed to improving long-term patient outcomes and transforming vascular health.

For more information, please visit: [www.solarisendovascular.com]

Randy Hubbell
Solaris Endovascular, Inc.
[email protected]
Visit us on social media:
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

You just read:

News Provided By

November 13, 2024, 13:30 GMT

Distribution channels:
Agriculture, Farming & Forestry Industry, Banking, Finance & Investment Industry, Beauty & Hair Care, Business & Economy, Chemical Industry, Companies, Conferences & Trade Fairs, Culture, Society & Lifestyle, Education, Emergency Services …


EIN Presswire’s priority is author transparency. We do our best to weed out false and misleading content. The content above is
the sole responsibility of the author who makes it available. If you have any complaints, kindly contact the author above.

Article originally published on www.einpresswire.com as Solaris Endovascular, Inc. Launches to Revolutionize Vascular Health Solutions Globally

Business

Post navigation

Previous Post: Maria Cecilia Conder selected as Top Board Member of the Year in Fine Arts by IAOTP
Next Post: Tech and Social Impact Leaders Converge at Goodera’s AI for Impact Summit

Related Posts

  • Aronora Announces Clinical Data to Be Presented at the 64th American Society of Hematology Annual Meeting
    Aronora Announces Clinical Data to Be Presented at the 64th American Society of Hematology Annual Meeting Business
  • Southwestern Scale Expands Into Colorado
    Southwestern Scale Expands Into Colorado Business
  • NetLine Academy Introduced as NetLine Aims to Better Educate B2B Demand Generation Marketers
    NetLine Academy Introduced as NetLine Aims to Better Educate B2B Demand Generation Marketers Business
  • Honig Vineyard and Winery, Family-Owned, Solar-Powered and Sustainably Farmed, Goes Topless
    Honig Vineyard and Winery, Family-Owned, Solar-Powered and Sustainably Farmed, Goes Topless Business
  • The Power of I Am Summit
    The Power of I Am Summit Business
  • Launch Cart, Inc. Announces Letter of Intent to Acquire Exchange Collective, Inc.
    Launch Cart, Inc. Announces Letter of Intent to Acquire Exchange Collective, Inc. Business
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
« Apr    
last celebrity gossip
Gossip Stone - celebrity life and gossip

Recent Posts

  • Thrive International Acquires Capelle Miami, Expanding Portfolio Into Premium Men’s Lifestyle MarketMay 21, 2025
  • Electric Vehicle (EV) Battery Cell and Pack Materials Market 2025: Growth, Trends, and ForecastMay 21, 2025
  • HII Reports First Quarter 2025 ResultsMay 21, 2025
  • New +/- 149,685 SF Industrial Lease in City of HamptonMay 20, 2025
  • KULR Launches Blockchain to Create Secure and Verifiable Supply ChainMay 20, 2025
Brand Values Content
VUGA Enterprises - media network PR & Marketing
  • Brian Binke, CEO of The Birmingham Group, Featured in Rigzone
    Brian Binke, CEO of The Birmingham Group, Featured in Rigzone World News
  • Ukraine city of Zaporizhzhia devastated by Russian rocket attacks – BBC News
    Ukraine city of Zaporizhzhia devastated by Russian rocket attacks – BBC News World News
  • War Day 663: System in disarray: women’s draft, listening devices, sociology.
    War Day 663: System in disarray: women’s draft, listening devices, sociology. World News
  • Life for Relief and Development (LIFE) Provides over 500 People with Hearing Services in Malawi
    Life for Relief and Development (LIFE) Provides over 500 People with Hearing Services in Malawi World News
  • Rising Cancer Incidence And Its Impact On Market
    Rising Cancer Incidence And Its Impact On Market World News
  • War Day 80: war diaries w/ Advisor to Ukraine President, Intel Officer @Alexey Arestovych & #Фейгин
    War Day 80: war diaries w/ Advisor to Ukraine President, Intel Officer @Alexey Arestovych & #Фейгин World News
  • Victorious Macron promises to unite France after defeating Le Pen – BBC News
    Victorious Macron promises to unite France after defeating Le Pen – BBC News World News
  • War Day 105: war diaries w/Advisor to Ukraine President, Intel Officer @Alexey Arestovych  & #Feygin
    War Day 105: war diaries w/Advisor to Ukraine President, Intel Officer @Alexey Arestovych & #Feygin World News
aerospace company
stem cell clinic in kiev
medical spa in miami
Fashion TV free

Copyright © 2023 195 News. All Rights Reserved by Coolaser | Partner of VUGA Enterprises |  Advertising: Get Published

Powered by .